![[Avant] Kit d'ensemble roulement de roue et moyeu pour 2016-2019 Subaru Legacy 2.5L KBB-103333 2005-mazda-mpv Numéro de pièce: KPF-100513 KDA-100498](https://cdn.shopify.com/s/files/1/0642/1105/8866/files/KBB-103333-01_f3c2a7c7-ab7b-483d-aa55-0bdcdaa4b65e.jpg?v=1771433712)
[Avant] Kit d'ensemble roulement de roue et moyeu pour 2016-2019 Subaru Legacy 2.5L KBB-103333 2005-mazda-mpv Numéro de pièce: KPF-100513 KDA-100498
EUR182.28EUR225.28
Pay in 4 interest-free payments of $45.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Harbor notes
Description
[Avant] Kit d'ensemble roulement de roue et moyeu pour 2016 2019 Subaru Legacy 2.5L KBB 103333 2005 mazda mpv Numéro de pièce: KPF 100513 KDA 100498 Numéro de pièce: KPF 100513 Numéro de pièce: KCX 100330 47034 BR901362 SU 716 488821769 7488821769 2488821769 901362 940801 610064 981957 ASU1009 BSU1009 DS1 SU 716 7994 9176 PF7994X SS7994X AD7994 QE7994X UP7994X D1521 1521 SCD1521 TEC D1521 Produit: Kit d'ensemble roulement de roue et moyeu (Wheel Bearing and Hub Assembly Kit)
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Frequently Asked Questions for [Avant] Kit d'ensemble roulement de roue et moyeu pour 2016-2019 Subaru Legacy 2.5L KBB-103333 2005-mazda-mpv Numéro de pièce: KPF-100513 KDA-100498
What should I check when reading a translated product listing?
Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.
How can I make a useful comparison table for several products?
Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.
How can I check whether a purchase involves ongoing commitments?
Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.